The scientific breakthrough enabling transplanted cells to evade the immune system originated from studying pregnancy. Researchers questioned why a mother's body doesn't reject a fetus, which is genetically half-foreign (from the father). Understanding this natural tolerance at the maternal-fetal border provided the blueprint for Sana's cloaking technology.

Up to 40% of natural conceptions are spontaneously aborted, often before a woman knows she's pregnant. This is typically the body's way of rejecting embryos with severe genetic abnormalities. This natural process provides a powerful biological precedent for the practice of pre-implantation genetic screening.

Research in mice challenges the idea that females simply run out of eggs. By treating old female mice, scientists rejuvenated their ovaries, enabling them to produce healthy offspring again, suggesting age-related infertility could be treatable.

Reversible cryopreservation is already a reality for human embryos, which have remained viable after 30 years in storage. The central challenge for companies like Until is not a fundamental scientific breakthrough, but rather solving the complex engineering problems of applying this proven concept to larger biological systems like organs.

Current incubators force underdeveloped lungs to breathe air. Varsavsky describes a 'liquid incubator' (like Vitara's) that uses artificial amniotic fluid and an umbilical cord, mimicking the womb. He predicts this far gentler alternative will make today's standard of care seem inhumane by comparison.

The technology for detecting cancer via cell-free DNA was discovered by accident. During non-invasive prenatal tests, some abnormal results weren't from the baby but from the mother's previously undiagnosed tumors shedding DNA, revealing an entirely new application for the technology.

A combination of medical necessity (saving the mother), the fetus's non-viability, and the exclusive use of pre-placental tissue creates a robust ethical framework for sourcing the earliest human stem cells, bypassing common moral barriers.

Beyond brains, research labs are now growing three-dimensional human uteruses from scratch. This breakthrough provides an unprecedented model to study the aging of the female reproductive system and test therapies aimed at extending fertility, potentially even after menopause.

By isolating pre-placental tissue from ectopic pregnancies—which are non-viable and routinely discarded—it's possible to source the earliest stem cells without the ethical dilemmas associated with embryonic stem cell research from IVF clinics.